Edgar Engleman, Director, 10% Owner at Bolt Biotherapeutics, Inc. (BOLT), bought 592,176 shares at $20.00 ($4.0M) on 2021-02-09, disclosed to the SEC on 2021-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 345,568 | $0 | 0.0% |
| 2 | $0.07 | 5,655 | $396 | 0.0% |
| 3 | $0.07 | 40,953 | $3K | 0.1% |
| 4 | $20.00 | 24,267 | $485K | 12.1% |
| 5 | $20.00 | 175,733 | $3.5M | 87.8% |
| Total | $6.76 avg | 592,176 |
| $4.0M |
| 100% |
| Filing → |
| BOLT | SELL | 2023-11-20 | $46K | — | Filing → |
| SLNO | BUY | 2017-12-19 | $4.0M | — | Filing → |
| CAPN | BUY | 2017-04-14 | $2.7M | — | Filing → |